Of note, the increased systemic ATX levels in the same ATX transgenic mouse were previously shown not to significantly affect the development of modelled chronic inflammatory diseases, such as bleomycin-induced pulmonary fibrosis [8], transgenic TNF-driven inflammatory arthritis [23] or experimental autoimmune encephalomyelitis [24]. The gene discussed is ENPP2; the disease is pulmonary fibrosis.